ReAlta Life Sciences Closes $20 Million Series A3 Financing to Advance Multiple Programs into Phase 2 Clinical Trials

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3gNeX7F
via IFTTT